Dow Jones 30 Stocks SEC Filings — March 27, 2026

27-03-2026

Shizuoka Financial Group, Inc. (Shizuoka FG) and The Bank of Nagoya, Ltd. entered into a Memorandum of Understanding (MOU) on March 27, 2026, to proceed with discussions toward a business integration via share exchange, targeting an effective date of April 1, 2028, under which Shizuoka FG will become the wholly-owning parent and The Bank of Nagoya a wholly-owned subsidiary, leading to delisting of Nagoya's shares. The integration aims to achieve synergies through broader-area collaboration, improved efficiency via shared resources, and enhanced capital efficiency (ROE), building on their existing 'Shizuoka Nagoya Alliance' since April 2022. As of December 31, 2025, Shizuoka FG reports consolidated total assets of ¥15,878,358 million and deposits of ¥12,101,303 million, while The Bank of Nagoya has ¥6,235,491 million and ¥5,384,984 million, respectively.

• ·Integration preparation committee to be co-chaired by Presidents Shibata and Fujiwara.
• ·Share exchange ratio to be determined post due diligence and third-party valuation.
• ·Definitive agreement scheduled for March 2027; Nagoya shareholder meeting December 2027.
• ·Shizuoka FG plans simplified share exchange without shareholder approval, subject to confirmation.

27-03-2026

J.P. Morgan Chase Commercial Mortgage Securities Corp. announced the execution of an Underwriting Agreement dated March 25, 2026, for the sale of Public Certificates with an aggregate initial principal amount of $722,002,000 and Private Certificates of $99,622,198, part of the BANK5 2026-5YR21 Commercial Mortgage Pass-Through Certificates, Series 2026-5YR21, backed by 31 commercial mortgage loans, with closing scheduled for April 17, 2026. The issuing entity will be formed under a Pooling and Servicing Agreement effective April 1, 2026, involving multiple servicers including Midland Loan Services and LNR Partners, LLC. Mortgage loans were acquired from JPMorgan Chase Bank, N.A., Bank of America, N.A., Wells Fargo Bank, N.A., and Morgan Stanley Mortgage Capital Holdings LLC.

• ·Mortgage loans include Hilton Waterfront Beach Resort, CityCenter (Aria & Vdara), Freeway Business Park, 1500 Post Oak Boulevard, Torrey Heights, Haven Leased Fee Portfolio, Coral Ridge Mall, Redstone Corporate Center I, Forty 540 II, SpringHill Suites Green Bay, 316 Business Center, Graham & Havemeyer Portfolio.
• ·Pooling and Servicing Agreement dated and effective as of April 1, 2026.
• ·Closing Date: April 17, 2026.
• ·Prospectus dated March 25, 2026, filed with SEC on March 27, 2026.

27-03-2026

Cyber Enviro-Tech, Inc. (CETI) entered into an Equity Purchase Agreement with Monroe Street Capital Partners, LP on March 20, 2026, providing the right to sell up to $30,000,000 of common stock over a 24-month Commitment Period, subject to conditions including put notices with minimum $25,000 and maximum $500,000 per put. As consideration, CETI issued 3,000,000 Initial Commitment Shares immediately and agreed to issue additional 3,000,000 Fulfillment Commitment Shares upon each of the first three $2,500,000 gross proceeds milestones. Concurrently, a Registration Rights Agreement requires filing a resale registration statement within 30 days and maintaining its effectiveness.

• ·Commitment Period: 24 months from March 20, 2026, or earlier termination events.
• ·Registration Statement filing deadline: within 30 calendar days after March 20, 2026.
• ·Registration effectiveness target: within 90 calendar days after filing.
• ·Common Stock trading symbol: CETI on OTCQB.
• ·Principal Executive Offices: 6991 E. Camelback Road, Suite D-300, Scottsdale, Arizona 85251.

27-03-2026

ADTRAN Holdings, Inc. (ADTN) filed a DEFA14A Definitive Additional Proxy Materials on March 27, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing covers the period from January 1, 2024, to December 31, 2024, but contains no substantive financial, operational, or voting details in the provided header. No quantitative metrics, improvements, declines, or performance data are disclosed.

• ·Filing Type: DEFA14A (Schedule 14A)
• ·Period Covered: 2024-01-01 to 2024-12-31

27-03-2026

Two Harbors Investment Corp. (TWO) announced a definitive merger agreement to be acquired by an affiliate of CrossCountry Mortgage (CCM) for $10.80 per share in cash, terminating its prior merger agreement with UWM Holdings Corporation dated December 17, 2025, and agreeing to pay a $25.4 million termination fee to UWM. The transaction, unanimously approved by TWO's board and recommended for stockholder approval, is expected to close in the second half of 2026, subject to customary conditions including regulatory approvals, with no financing condition. Holders of TWO's preferred stock will be redeemed at $25.00 per share plus accumulated dividends, while TWO plans to continue regular quarterly dividends prior to closing but no partial dividend in the closing quarter.

• ·TWO's prior stockholder meeting scheduled for April 7, 2026, to approve UWM merger has been canceled.
• ·Transaction not subject to financing condition; TWO common stock to be delisted from NYSE upon closing.
• ·Advisors: Houlihan Lokey (financial) and Jones Day (legal) for TWO; Citigroup (financial) and Simpson Thacher & Bartlett (legal) for CCM.

27-03-2026

Norwegian Cruise Line Holdings Ltd. (NCLH) announced the appointment of five new independent directors effective March 31, 2026—Alex Cruz, Kevin A. Lansberry, Steve Pagliuca, Brian P. MacDonald, and Jonathan Z. Cohen—following a cooperation agreement with Elliott Investment Management L.P. to enhance board refreshment and shareholder value. Four directors—Stella David, David M. Abrams, Harry C. Curtis, and Mary E. Landry—will resign, resulting in a nine-member board with eight independents; John W. Chidsey is appointed Chairman and Alex Cruz as Lead Independent Director. The changes aim to improve execution amid strategic growth, with NCLH's fleet at 35 ships and nearly 75,000 Berths, planning 16 more ships adding over 43,000 Berths by 2037.

• ·Company slate for 2026 Annual General Meeting: Zillah Byng-Thorne, Linda P. Jojo, Alex Cruz.
• ·Elliott agreed to customary standstill and voting commitments in cooperation agreement.
• ·Advisors: Goldman Sachs & Co. LLC (financial), Paul Hastings LLP (legal), Joele Frank, Wilkinson Brimmer Katcher (strategic communications).

27-03-2026

Everus Construction Group, Inc. filed Definitive Additional Materials (DEFA14A) on March 27, 2026, as a proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is classified as soliciting material under §240.14a-12. No financial metrics, performance data, or substantive proxy details are provided in the document header.

27-03-2026

Allegiant Travel Company entered into a Merger Agreement on January 11, 2026, to acquire Sun Country Airlines in a stock-and-cash transaction, with each Sun Country share converting to $4.10 cash and 0.1557 shares of Allegiant stock; pro forma combined results for 2025 show total operating revenues of $3,738,443 thousand and operating income of $81,158 thousand, reflecting revenue growth from combined historical figures of $2,606,579 thousand (Allegiant) and $1,127,346 thousand (Sun Country). However, pro forma net loss widened slightly to $(42,620) thousand from Allegiant's historical $(44,697) thousand despite Sun Country's $52,809 thousand profit, driven by transaction adjustments and higher interest expense. The pro forma balance sheet as of December 31, 2025, reflects combined total assets of $5,836,518 thousand, up significantly from Allegiant's $4,209,401 thousand.

• ·Sun Country Warrant to Amazon Holder exercisable at $15.17 per share for up to 9,482,606 shares, to be exercised net issuance basis prior to closing.
• ·Change-in-control payments include $5.7M vested retention bonuses at closing, $4.0M retention 90 days post-closing, $0.3M pro-rated incentives within 30 days, and $2.2M dispatcher bonuses two years post-closing subject to milestones.
• ·All Sun Country equity awards convert to Allegiant equivalents based on 0.1557 Merger Exchange Ratio; PRSU awards at 125% performance factor become time-based.
• ·Pro forma EPS basic and diluted: $(1.58); shares used basic 27,015 thousand, diluted 27,015 thousand.
• ·Accounting policy differences noted in maintenance recognition and investment classification.

27-03-2026

Kopin Corporation reported preliminary Q4 2025 total revenues of $8.4 million, down 42% YoY from $14.6 million, driven by a 56% decline in product revenues to $5.6 million due to government shutdown delays in defense orders and shipments. Non-product revenues increased 47% to $2.5 million, supported by programs like IBAS color MicroLED development. The company strengthened its balance sheet via a $56 million private placement from strategic investors, with cash at $37.8 million, while advancing partnerships with Theon International and maintaining a strong defense pipeline.

• ·Cost of product revenues was 83% of net product revenues in Q4 2025 vs 84% in Q4 2024, stable due to product mix, quality improvements, cost containment, and automation despite lower volume.
• ·R&D expenses increased modestly to $3.5 million from $3.1 million, supporting internal technology development including MicroLED advancements.
• ·SG&A expenses rose to $4.5 million from $3.1 million due to professional fees for capital raise and partnerships.
• ·Government shutdown impacts expected to continue into Q1 2026.

27-03-2026

Bed Bath & Beyond, Inc. (BBBY-WT) filed a DEFA14A Definitive Additional Proxy Materials on March 27, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing is marked as filed by the registrant with no fee required and contains no substantive proposals, financial data, or additional details in the provided excerpt.

27-03-2026

Indivior Pharmaceuticals, Inc. has filed definitive additional proxy materials for its 2026 Annual Meeting on May 13, 2026, at 10:00 a.m. ET virtually via www.virtualshareholdermeeting.com/INDV2026. Key proposals include the election of eight director nominees (board recommends FOR all), an advisory vote to approve named executive officer compensation (FOR), preferred frequency of say-on-pay votes (1 Year), and ratification of PricewaterhouseCoopers LLP (US) as independent auditor for FY ending December 31, 2026 (FOR). No financial metrics or performance comparisons are provided in this notice.

• ·Vote by May 12, 2026 11:59 PM ET at www.ProxyVote.com
• ·Request proxy materials by April 29, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
• ·Control numbers: V88256-P50034, V88257-P50034

27-03-2026

On March 23, 2026, Barnwell Industries, Inc. issued a press release announcing a cash distribution received from its minority partnership interests and providing a corporate update regarding its asset base and value-maximization efforts. The press release is incorporated as Exhibit 99.1. No specific financial figures or performance metrics were detailed in the filing.

• ·Filing submitted on March 27, 2026, reporting event dated March 23, 2026.
• ·Company headquarters: 24 Greenway Plaza, Suite 1800Q, Houston, Texas 77046.

27-03-2026

BHAV Acquisition Corp, a blank check company, consummated its IPO on March 20, 2026, selling 10,000,000 units at $10.00 per unit, generating $100,000,000 in gross proceeds. Simultaneously, it completed a private placement of 200,000 units at $10.00 per unit to its sponsor BHAV Partners LLC and others, yielding $2,000,000. A total of $100,000,000 was placed in a trust account at $10.00 per unit for public shareholders.

• ·Total assets as of March 20, 2026: $101,085,982
• ·Total current liabilities: $223,281 (including $114,381 accrued offering costs and $93,900 over-allotment option liability)
• ·Shareholders' equity: $862,701 (with accumulated deficit of $113,753)
• ·Company focuses on business combinations in advanced robotics, EVs, drones, UAS, or fintech sectors
• ·Sponsor purchased 135,000 private units; at-risk capital investors purchased 65,000

27-03-2026

Kodiak Sciences Inc. announced positive topline results from GLOW2, its second Phase 3 study in diabetic retinopathy, demonstrating superiority of Zenkuda™ (tarcocimab tedromer) over sham. The press release detailing these results is attached as Exhibit 99.1 and incorporated by reference. The filing was signed by CEO Victor Perlroth, M.D. on March 26, 2026.

• ·Filing date: March 27, 2026; Date of earliest event: March 26, 2026
• ·Registrant details: Delaware incorporation, CIK 0001468748, Nasdaq: KOD
• ·Principal offices: 1250 Page Mill Road, Palo Alto, CA 94304

27-03-2026

On March 25, 2026, Honda Canada Finance Inc. (HCFI), a subsidiary of American Honda Finance Corp., executed the Second Amendment to its C$2,000,000,000 ($1,455,498,144.20 USD) Third Amended and Restated Credit Agreement, extending the Tranche A commitment termination date from March 25, 2026, to March 25, 2027 (up to C$1,000,000,000 or $727,749,072.12 USD), and Tranche B from March 25, 2027, to March 25, 2029 (up to C$1,000,000,000 or $727,749,072.12 USD). The amendment also permits further extension of Tranche B commitments up to three years upon HCFI request and updates a reference date in Section 8.4 from March 31, 2024, to March 31, 2025. No declines or flat metrics reported; the changes enhance liquidity access.

• ·Exchange rate used for USD conversions: 1.3741 CAD per USD as of March 23, 2026.
• ·Amendment filed as Exhibit 10.1.

27-03-2026

PetVivo Holdings, Inc. entered a Subscription Agreement on March 13, 2026, for $1,000,000 in equity financing in exchange for 1,250,000 units priced at $0.80 per unit, consisting of one restricted common stock share and one warrant each. The company received $400,000 initially on March 13, 2026, with the remaining $600,000 due by April 15, 2026; the investor also holds an option for an additional $1,500,000 investment for 1,875,000 units by June 30, 2026. Warrants are immediately exercisable at $1.10 per share and expire in three years.

• ·Offering conducted pursuant to Section 4(a)(2) of the Securities Act and Regulation D exemption.
• ·Investor represented as accredited; securities are restricted under Rule 144 with appropriate legends.
• ·This is Amendment No. 1 to Form 8-K, date of report March 16, 2026, filed March 27, 2026.

27-03-2026

BitGo Holdings, Inc. reported total revenue of $16,152,121 thousand for the year ended December 31, 2025, up 424% YoY from $3,080,967 thousand in 2024, primarily driven by digital assets sales surging to $15,577,366 thousand. However, the company recorded a net loss of $14,782 thousand compared to a $156,554 thousand profit in 2024, due to a $38,708 thousand net unrealized loss on digital assets and total expenses at nearly 100% of revenue. Adjusted EBITDA improved to a positive $32,411 thousand from $3,227 thousand, reflecting operational leverage despite the net loss.

• ·Digital assets sales cost was 96.2% of revenue in 2025, up from 82.2% in 2024.
• ·Gain on disposal of assets was $117,427 thousand in 2024, but only $11,109 thousand in 2025.
• ·Compensation and benefits expenses grew to $104,171 thousand in 2025 from $79,939 thousand in 2024.
• ·Filing date: March 27, 2026.

27-03-2026

Apollo Asset Backed Credit Co LLC's total assets grew significantly to $1,887,194 as of December 31, 2025 from $296,870 in 2024 (up 536% YoY), driven by investments at fair value surging to $1,577,705 (up 639% YoY) and net assets to $1,612,110 (up 481% YoY). Total investment income rose sharply to $64,943 (up 1,540% YoY) from $3,962, resulting in net investment income of $42,880 and net increase in net assets from operations of $65,052 (up 2,016% YoY). However, cash flows from operating activities deteriorated to $(1,413,805) from $(221,002) (more negative by 540% in magnitude), and net increase in cash declined 53% to $27,594 from $58,585.

• ·Net asset value per share for A-I Shares averaged $25.52 as of Dec 31, 2025 (up from $25.18).
• ·Level III assets balance grew to $1,068,004 as of Dec 31, 2025 from $73,377.
• ·Provision for income taxes totaled $2,267 for year ended Dec 31, 2025.
• ·Special Purpose Vehicles represent 23.64% of total investments at fair value as of Dec 31, 2025.

27-03-2026

SpringBig Holdings, Inc. reported revenue of $22,834 thousand for the year ended December 31, 2025, down 7.4% from $24,649 thousand in 2024, with net loss widening to $3,247 thousand from $1,876 thousand. The number of retail clients declined 15.3% to 775 from 915, and net revenue retention fell to 79% from 88%, while the number of messages increased 4.7% to 624 million; Adjusted EBITDA decreased 36.1% to $874 thousand from $1,368 thousand. The company highlighted risks including a significant working capital deficiency, history of losses, and challenges in client retention and market expansion.

• ·Adjustments to EBITDA include stock-based compensation of $481 thousand, credit loss expense of $820 thousand, and severance payments of $808 thousand in 2025.
• ·2024 EBITDA adjustments included gain on repurchase of convertible debt of $1,573 thousand offset by loss on debt extinguishment of $636 thousand.

27-03-2026

PMGC Holdings Inc.'s wholly-owned subsidiary Northstrive Biosciences Inc. entered into the Third Amendment to its License Agreement with MOA Life Plus Co., Ltd. on March 24, 2026, amending Exhibit C to update development milestones and timelines for the human health field, including pre-clinical studies, IND submission, and Phases 1-3 trials leading to FDA marketing approval (specific timelines redacted). The amendment includes a provision allowing Northstrive to potentially skip the Phase 1 clinical trial for the licensed product BLS-M22 and proceed directly to Phase 2 under certain conditions, with the associated milestone payment combined. As consideration, PMGC must pay a one-time, non-creditable, non-refundable amendment fee (amount redacted) upon execution and within 30 days.

• ·Original License Agreement dated April 30, 2024; First Amendment in March 2025 expanding field to animal health; Second Amendment on May 12, 2025 clarifying animal health provisions.
• ·Assignment of original agreement from PMGC to Northstrive on February 28, 2025.

27-03-2026

Reliance Global Group, Inc. issued a press release on March 25, 2026, announcing the launch of RELI Exchange 2.0, furnished as Exhibit 99.1 under Regulation FD Disclosure. The filing includes standard company details such as its Florida incorporation, NASDAQ listings for common stock (EZRA, par value $0.086 per share) and Series A Warrants (EZRAW). No financial metrics or performance data were disclosed.

• ·Securities registered: Common Stock (EZRA, par value $0.086 per share) and Series A Warrants (EZRAW) on The NASDAQ Capital Market.
• ·Company address: 300 Blvd. of the Americas, Suite 105, Lakewood, New Jersey 08701.
• ·IRS Employer Identification No.: 46-3390293.

27-03-2026

Volato Group, Inc. (SOARW) filed an S-4/A amendment on March 27, 2026, disclosing financial statement tags and pro forma data related to a potential business combination with M2i Global Inc., including balance sheet items as of 2025-12-31 and 2024-12-31. The filing references discontinued operations of GCAviation Inc. disposed on March 20, 2025, and agreements such as the Aircraft Management Services Agreement with FlyExclusive effective October 1, 2025. No specific monetary figures, growth, or declines are provided in the excerpt.

• ·Discontinued operations disposed by sale: GCAviation Inc on 2025-03-20
• ·Volato Group Inc and M2i Global Inc transaction referenced on 2025-07-28
• ·Aircraft Management Services Agreement with FlyExclusive effective 2025-10-01
• ·Share Exchange Agreements period: 2025-09-01 to 2025-09-30
• ·Convertible debt references including Third Tranche Note, Fourth Tranche Note, and various 2024/2026 notes as of 2025-12-31

27-03-2026

JFB Construction Holdings and XTEND announced the rapid mobilization of XTEND's global XFAB operator network, deploying personnel from the US and Latvia to the UK to support allied defense missions in response to an Israeli Ministry of Defense request. This update follows their February 17 definitive all-stock merger agreement, supported by strategic investments from Eric Trump, Unusual Machines, American Ventures LLC, Protego Ventures, and Aliya Capital, with the combined entity expected to be renamed XTEND AI Robotics and listed under ticker XTND. XTEND highlights its operational readiness, with over 10,000 systems deployed in more than 30 countries across five combat zones.

• ·XTEND manufacturing facilities located in the U.S., U.K., Singapore, Israel, and Latvia.
• ·XTEND founded in Tel Aviv, Israel, and headquartered in Tampa, Florida.
• ·Solutions are NDAA-compliant.

27-03-2026

Clear Channel Outdoor Holdings, Inc. disclosed updated director biographies for Lisa Hammitt and Joe Marchese, emphasizing their extensive technology, AI, and advertising expertise. Key 2025 compensation decisions included base salary increases for NEOs such as Mr. Wells to $1,200,000 (from $1,100,000), Ms. Feldman and Mr. Sailer to $750,000 (from $650,000), and annual incentive payouts at 107%-119% of target due to above-target performance and successful sales of Latin American and European businesses. 2025 equity grants were awarded with grant date fair values from $352,493 to $4,015,083, featuring significant performance-based PSUs tied to Relative TSR and Adjusted EBITDA less CapEx.

• ·Equity grant mixes: Mr. Wells 40% RSUs / 60% PSUs; Mr. Sailer and Ms. Feldman 45% RSUs / 55% PSUs; Mr. Dilger 75% RSUs / 25% PSUs.
• ·RSUs vest in three equal installments on April 1, 2026, 2027, and 2028.
• ·PSUs performance period: April 1, 2025 to March 31, 2028; capped at 100% payout if TSR < 0.
• ·Annual Incentive Plan: 70% Plan Adjusted EBITDA, 30% individual objectives.
• ·Company revenues at 32nd percentile of peer group; target NEO comp at 50th percentile.

27-03-2026

SBC Medical reported Q4 2025 total revenues of $40 million, down 11% YoY, but net income attributable to SBC Medical Group more than doubled to $14 million (+117% YoY) with EPS of $0.14 (+133% YoY), though EBITDA declined 35% to $14 million with margin contracting 12 percentage points to 34%. Full year 2025 revenues fell 15% to $174 million, partially offset by net income growth of 9% to $51 million and EPS of $0.50 (+4% YoY), while EBITDA dropped 21% to $70 million with margin down 3 points to 40%. Franchise locations increased to 283 (+34 YoY) and customers reached 6.6 million (+12% YoY), with Q4 average revenue per customer up 11% to $316.

• ·Cash and cash equivalents increased to $163,773,838 from $125,044,092 YoY.
• ·Total assets grew to $380,447,946 from $266,083,154 YoY.
• ·Conference call scheduled for March 27, 2026 at 8:30 am ET.
• ·Repeat customer rate of 72% for SBC brand, Rize, and Gorilla clinics.
• ·Net income margin expanded from 23% to 29% for FY2025.

27-03-2026

RenovoRx, Inc. appointed Ramtin Agah, M.D., its Chief Medical Officer and Chairman of the Board, to the newly created position of Executive Chairman, effective February 27, 2026, via an offer letter dated March 24, 2026. The agreement sets Dr. Agah's annualized base salary at $450,000 (effective January 1, 2026, for at least 30 hours per week), with eligibility for a discretionary annual bonus up to 40% of base salary (first payable in 2027) and annual equity grants under the 2021 Omnibus Equity Incentive Plan. Employment is at-will, with customary confidentiality, IP, and severance provisions remaining in effect.

• ·Appointment formalized by Board on March 24, 2026; offer letter amends and restates prior Consulting Agreement dated January 1, 2018.
• ·Amended and Restated Change in Control and Severance Agreement dated November 10, 2025 remains in full force.
• ·Base salary payable semi-monthly based on minimum 30 hours worked per week.
• ·Equity awards subject to 2021 Omnibus Equity Incentive Plan (or successor) with vesting tied to continued service.

27-03-2026

Dine Brands Global, Inc. issued definitive additional proxy materials for its 2026 Annual Meeting of Stockholders on May 14, 2026, at 8:00 A.M. MDT in Boise, Idaho, where shareholders will vote on electing ten directors, ratifying KPMG LLP as independent auditors for fiscal 2026, advisory approval of executive compensation, and competing proposals on special meeting rights (board-supported at 25% ownership threshold vs. stockholder-proposed at 15%, which the board opposes). The board recommends voting FOR proposals 1-4 and AGAINST proposal 5. Proxy materials and 2025 Annual Report are available online at www.envisionreports.com/DIN, with paper requests due by May 1, 2026, and electronic votes due by 8:00 A.M. MT on meeting day.

• ·Meeting location: 500 South Capitol Boulevard, Boise, Idaho 83702
• ·Proxy material requests must be received by May 1, 2026 for timely delivery

27-03-2026

HG Holdings, Inc. reported total revenue of $14,736 for the year ended December 31, 2025, up 28% YoY from $11,513, driven by strong 66.5% growth in management fees to $5,000 and 15.5% increase in net premiums written to $6,941, swinging to net income attributable to shareholders of $1,529 from a $239 loss. Total assets grew 20.1% to $50,686 and stockholders' equity rose 30.7% to $41,685. However, net cash provided by operating activities declined 55.2% to $878 from $1,961, other net expenses worsened sharply to $(2,348) from $1,394 due to related party investment losses, and cash and equivalents plus restricted cash fell to $17,079.

• ·Provision for title claim losses decreased to $119 from $328.
• ·Net investment income declined to $725 from $1,058.
• ·Loss from investments in related parties, net was $(3,084) vs $(815).
• ·Income tax benefit of $2,737 in 2025 vs $18.
• ·Common stock repurchases totaled $4,381 in 2025 vs $243 in 2024.
• ·Issuance of common stock raised $12,470.

27-03-2026

3M Company filed Definitive Additional Materials (DEFA14A) as a proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 on March 27, 2026. The filing was made by the registrant with no fee required. No specific financial metrics, performance data, or shareholder proposals are detailed in the provided filing header.

• ·Filing categorized as Definitive Additional Materials.

27-03-2026

Avantor, Inc. (AVTR) filed Definitive Additional Proxy Soliciting Materials (DEFA14A) on March 27, 2026, as additional materials related to a proxy statement under Section 14(a) of the Securities Exchange Act of 1934. The filing primarily contains metadata, company details such as CIK 0001722482 and address in Radnor, PA, and embedded image data (nanda1.jpg), with no financial metrics, performance data, or substantive proxy details provided. No positive or negative developments are disclosed.

• ·Filing Type: DEFA14A (Definitive Additional Proxy Soliciting Materials)
• ·SEC File Number: 001-38912
• ·Fiscal Year End: December 31
• ·SIC: LABORATORY ANALYTICAL INSTRUMENTS [3826]
• ·EIN: 822758923
• ·Business Address: Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road, Radnor, PA 19087

27-03-2026

Victory Capital Holdings, Inc. (VCTR) filed its DEF 14A Proxy Statement on March 27, 2026, for the virtual 2026 Annual Meeting of Stockholders on May 6, 2026, at 8:00 a.m. ET. Key proposals include the election of Class II directors to serve until the 2029 annual meeting, ratification of Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026, and a non-binding advisory vote to approve named executive officer compensation. The record date for shareholders entitled to vote is March 10, 2026.

• ·Meeting accessible via www.virtualshareholdermeeting.com/VCTR2026 using control number from Notice or proxy card.
• ·Proxy materials and 2025 Form 10-K available at www.proxyvote.com.
• ·Vote required: Plurality for director election; Majority for auditor ratification and advisory compensation vote.

27-03-2026

VisionWave Holdings, Inc. announced the completion of an internal research paper evaluating radio-frequency (RF)-based subsurface sensing architectures as part of its long-term strategic initiatives. The announcement was made via a press release furnished under Item 7.01. No financial metrics or performance data were disclosed.

27-03-2026

Virtuix Holdings Inc. announced that the U.S. Marine Corps Training and Education Command (TECOM), through strategic partner KBR, has purchased an Omni One omni-directional treadmill system for experimentation in warfighter training and mission planning, with delivery scheduled to the TECOM Integration Lab in Quantico, Virginia, in April 2026. This sale expands Virtuix’s defense footprint following prior deployments to the U.S. Military Academy at West Point, U.S. Air Force Academy, and Yokota Air Base. CEO Jan Goetgeluk highlighted the growing momentum in military applications for full-body VR technologies like Virtual Terrain Walk (VTW).

• ·System purchased for evaluation in support of operational planning, mission rehearsal, and combat readiness training.
• ·VTW enables multi-user AI-driven 3D reconstruction of real-world environments for physical navigation in geo-specific virtual worlds.

27-03-2026

Adagio Medical Holdings, Inc. reported zero revenue for the full year ended December 31, 2025, a 100% decline from $602 thousand combined in 2024 (Successor $269 thousand + Predecessor $333 thousand), contributing to a net loss of $25,084 thousand. While total operating expenses decreased 16% to $21,890 thousand and no impairments were recorded (vs. $49,202 thousand in 2024 Successor), loss from operations was $21,890 thousand and cash used in operating activities rose to $19,014 thousand. Cash and equivalents ended at $17,105 thousand, down from $20,586 thousand, supported by $16,134 thousand from financing activities.

• ·Convertible notes payable increased to $21,040 thousand from $16,076 thousand.
• ·Total liabilities $30,851 thousand at Dec 31 2025 vs $28,536 thousand at Dec 31 2024.
• ·Accumulated deficit grew to $95,609 thousand from $70,586 thousand.
• ·Basic net loss per share $ (1.51) for 2025 Successor vs $ (3.38) 2024 Successor.
• ·Risks include potential inability to refinance Convertible Securities Notes and impacts from proposed tariffs on gross margins.

27-03-2026

Ally Auto Receivables Trust 2022-3 filed its 10-K annual report on March 27, 2026, covering the year ended December 31, 2025. Financial statements and schedules are not applicable; the filing primarily lists exhibits including formation agreements from December 14, 2022, and compliance reports from Ally Bank and U.S. Bank Trust Company, National Association. No operational or financial performance metrics are disclosed.

• ·Compliance reports cover activities for year ended December 31, 2025, with attestations dated March 6, 2026 (Ally Bank) and February 26, 2026 (U.S. Bank Trust Company, National Association).
• ·Key exhibits include agreements dated December 14, 2022 (Indenture, Trust Agreement, Pooling Agreement, etc.) and Second Amended and Restated Limited Liability Company Agreement dated November 7, 2018.